ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

Senate Committee Blocks Effort To Overturn Organ Systems Changes

December 10, 1982

Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers

September 28, 2012

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009